Ignite Creation Date:
2024-05-06 @ 12:13 PM
Last Modification Date:
2024-10-26 @ 12:56 PM
Study NCT ID:
NCT03709446
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2018-10-14
Brief Title:
Leflunomide in Previously Treated Metastatic Triple Negative Cancers
Sponsor:
Joseph Sparano
Organization:
Icahn School of Medicine at Mount Sinai
Organization Data
Organization:
Icahn School of Medicine at Mount Sinai
Class:
OTHER
Study ID:
GCO 18-1832
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Joseph Sparano
Lead Sponsor Class:
OTHER
Responsible Party:
Joseph Sparano
Responsible Party Title:
Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Icahn School of Medicine at Mount Sinai
Old Name:
None
Old Organization:
None